| Dr Sarah Brown, PHARM D | |
|
900 E Ross St, Clearwater, KS 67026-7849 | |
| (620) 584-4042 | |
| (620) 584-4044 |
| Full Name | Dr Sarah Brown |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 900 E Ross St, Clearwater, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801270681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 12783 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Brown, PHARM D 900 E Ross St, Clearwater, KS 67026-7849 Ph: (620) 584-4042 | Dr Sarah Brown, PHARM D 900 E Ross St, Clearwater, KS 67026-7849 Ph: (620) 584-4042 |
News Archive
A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD). Details of the study are available in the July issue of Liver Transplantation, published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
AdvantEdge Healthcare Solutions, one of the nation's leading providers of medical billing, practice management, and coding services for specialty physicians, hospitals, and surgery centers, is launching its QualityEdgeSM information capture service, which allows physicians and other providers to easily capture data that would otherwise require paper notes or the use of an EMR.
Trying to get fit but can't work it into your daily schedule? Incorporating even relatively short bouts of exercise into a daily commute appears to deliver significant rewards, according to a new study from the University of North Carolina at Chapel Hill.
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced that the UK Intellectual Property Office (IPO) has rejected a revocation action brought by Biogene against three patents licensed exclusively to Enigma by the Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence.
Covalon Technologies Ltd. (the "Company" or "Covalon"), an advanced medical technologies company, today announced that further to its press release of August 16, 2013, it has completed, subject to final approval of the TSX Venture Exchange, a non-brokered private placement comprised of 750 units (the "Units") at a price of $1,000 per Unit for gross proceeds of $750,000. Each Unit consists of $1,000 principal amount of 12% senior secured convertible debenture (the "Debentures" and each a "Debenture") and 6,451 warrants (each, a "Warrant").
› Verified 8 days ago
Roger A. Bales, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 116 E Ross St, Clearwater, KS 67026 Phone: 620-584-2025 | |
Nancy Milledge, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 E Ross St, Clearwater, KS 67026 Phone: 620-584-4044 Fax: 620-584-4044 |